Monday, July 23, 2018
 
 
Company News: Page (1) of 1 - 07/11/18 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Novanta Inc. Schedules Earnings Release and Conference Call for Wednesday, August 8, 2018
 
(July 11, 2018)

BEDFORD, Mass., July 11, 2018 /PRNewswire/ -- Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its second quarter 2018 results on Wednesday, August 8, 2018.

The Company will host a conference call on Wednesday, August 8, 2018 at 10:00 a.m. ET to discuss these results.  To access the call, please dial (877) 870-4263 prior to the scheduled conference call time.  Alternatively, the conference call can be accessed online via a live webcast on the Event Calendar page of the Investor Relations section of the Company's website at www.novanta.com.

A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the Investor Relations section of the Company's website at www.novanta.com. The replay will remain available until Friday, October 5, 2018.



About Novanta

Novanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary technology expertise and competencies in photonics, vision, and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT."

More information about Novanta is available on the Company's website at www.novanta.com.  For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or [email protected].

* * *

Novanta logo

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/novanta-inc-schedules-earnings-release-and-conference-call-for-wednesday-august-8-2018-300679761.html

SOURCE Novanta Inc.

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords: Inc.,
Related Sites: DMN Newswire ,   itbusinessnet.com ,   HTN - Health Technology Net
Related Newsletter: DMNForums ,   Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
Seniors

Drugs
  • Healthcare IT Market 2018 - 2023 with SWOT Analysis regarding upcoming Changes and Technology Adaptations in Global Healthcare Sector
  • Sciatica Market Research Valued 18.9 Billion US$ by 2023: A Comprehensive Sciatica Market Growth by by type, by Drug Treatment and by End User
  • Medical Sensors Market to be Worth US$18.74 Billion by 2023, Says TMR
  • Vision Care Product Market To Witness Enhanced Growth Owing To Rising Occurrence Of Eye Disorders Till 2021 | Million Insights
  • Global Prosthetic Heart Valve Market Reaching at a CAGR of +12.70% by Geography, Deployment Model, Component, and Key players are Boston Scientific Cardiology, CryoLife, Inc., Abbott

    Cancer
  • CStone Pharmaceuticals Appoints Former Goldman Sachs Executive Richard Yeh as CFO
  • Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy
  • CytRx Corporation Announces Expiration of Outstanding Warrants
  • HedgePath Pharmaceuticals Granted Exclusive Option to License UCONN's Patented Chemical Analogues of Itraconazole
  • Alligator Bioscience Submits Application to Start Clinical Phase I Study in Cancer Patients with ATOR-1015, a Unique CTLA-4 and OX40 Binding Antibody
  •  
     
     
     
     
     





    Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines